Actionnariat et activité des initiés pour RxSight, Inc. (RXST): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $5.40 |
| Capitalisation | $224M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-15 | Weinberg Eric | M-Exempt | 35,168 | $153K |
| 2026-09-15 | Weinberg Eric | M-Exempt | 35,168 | $153K |
| 2026-09-05 | Wilterding Mark | A-Award | 258,770 | $1.6M |
| 2026-09-05 | Wilterding Mark | D-Return | 258,770 | $2.6M |
| 2026-09-05 | Weinberg Eric | A-Award | 93,984 | $599K |
| 2026-09-05 | Weinberg Eric | A-Award | 82,608 | $527K |
| 2026-09-05 | Weinberg Eric | A-Award | 65,742 | $419K |
| 2026-09-05 | Weinberg Eric | A-Award | 59,483 | $379K |
| 2026-09-05 | Weinberg Eric | A-Award | 32,258 | $206K |
| 2026-09-05 | Weinberg Eric | D-Return | 95,000 | $1.4M |
Bilan (10 ans)
| Année | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Trésorerie | $8.0M | $14.0M | $24.4M | $11.8M | $9.7M | $16.7M | $19.9M |
| Placements à Court Terme | $72.7M | $55.0M | $135.0M | $94.0M | $117.5M | $220.5M | $208.2M |
| Créances | $789000 | $2.9M | $4.9M | $11.0M | $20.3M | $30.1M | $23.4M |
| Stocks | $7.2M | $8.3M | $8.0M | $14.8M | $17.4M | $22.0M | $31.6M |
| Actifs Courants | $90.2M | $81.5M | $176.3M | $134.6M | $168.4M | $293.8M | $287.5M |
| Immobilisations Corporelles | $19.2M | $18.6M | $15.5M | $14.1M | $13.3M | $23.6M | $23.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $110.4M | $100.7M | $192.7M | $150.2M | $182.6M | $318.6M | $311.8M |
| Dettes Fournisseurs | $2.2M | $1.1M | $1.7M | $2.6M | $3.9M | $4.5M | $5.3M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | $974000 | 0 |
| Passifs Courants | $8.5M | $11.6M | $11.1M | $17.2M | $20.9M | $25.9M | $26.3M |
| Dette à Long Terme | 0 | $24.4M | $39.8M | $40.2M | 0 | 0 | $9.9M |
| Passifs Totaux | $415.0M | $398.2M | $54.5M | $60.3M | $22.2M | $37.3M | $36.1M |
| Réserves | -$419.9M | -$430.6M | -$479.3M | -$546.0M | -$594.6M | -$622.1M | -$661.0M |
| Capitaux Propres | -$304.6M | -$297.5M | $138.2M | $89.9M | $160.4M | $281.2M | $275.7M |
| Dette Totale | $5.5M | $30.8M | $44.9M | $45.0M | $3.0M | $12.3M | $11.0M |
| Dette Nette | -$75.2M | -$38.2M | -$114.4M | -$60.8M | -$124.2M | -$224.9M | -$217.1M |
| Fonds de Roulement | $81.7M | $69.9M | $165.2M | $117.3M | $147.5M | $267.9M | $261.2M |
Santé financière
| Dette / Capitaux propres | 0.04 |
| Ratio de liquidité | 4.07 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 5.08 |
Rentabilité
| Rentabilité des capitaux propres | -17.35% |
| Rentabilité du capital investi | -20.12% |
| Rentabilité des actifs | -13.31% |
| Marge brute | 77.50% |
| Marge opérationnelle | -43.20% |
| Marge nette | -36.80% |
Entreprises liées: BFLY · CERS · DCTH · DMAC · KIDS · NPCE · SMLR
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de RXST: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions